Summary
- Current Price
- As of today, BDTX price is $2.15, down -0.92% on
- Current Price All-Time High
- BDTX price is currently -95.35% below its historical high of $46.25 set on
- Market Cap
- BDTX current market cap is $122M, up +25.69% over the past 365 days
- PE Ratio
- BDTX current PE ratio is 5.65
- Revenue
- BDTX current annual revenue is $70.00M, up +100.00% year-over-year
- Next Earnings
- The next earnings release for BDTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Black Diamond Therapeutics, Inc. |
| Ticker | NASDAQ: BDTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | blackdiamondtherapeutics.com |
| Employees | 24 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.15 | ||
| Price, 1D Change | -0.92% | |
| $122M | ||
| - | ||
| 5.65 | ||
| 1.51 | ||
| $70M | ||
| Revenue, 1Y Change | +100.00% | |
| $0.39 | ||
| EPS, 1Y Change | +130.69% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.39 | ||
| EPS Estimate | N/A | -$0.60 |
| EPS Est. Change | N/A | -254.40% |
| $70.00M | ||
| Revenue Estimate | N/A | $8.33M |
| Revenue Est. Change | N/A | -88.10% |
| $2.15 | ||
| Price Target | - | $9.00 |
| Price Tgt. Change | - | +318.60% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.98 | -$1.88 | +5.27% | |
| -$1.27 | -$1.27 | +0.17% | |
| $0.42 | $0.39 | -7.85% | |
| -$0.60 | N/A | -254.40% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $70.00M | $70.00M | 0.00% | |
| $8.33M | N/A | -88.10% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +25.00% | ||
| +31.90% | ||
| +25.69% | ||
| +105.97% | ||
| +100.00% | ||
| +100.00% | ||
| +130.69% | ||
| +115.48% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $2.15 | ||
| $2.94 | ||
| SMA 200 vs Price | +36.79% | |
| $2.41 | ||
| SMA 50 vs Price | +12.11% | |
| 1.51 | ||
| $0.15 | ||
| 42.69 | ||
| 50.70% | ||
| 76.28% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $70.00M | ||
| $0.39 | ||
| $69.68M | ||
| 99.54% | ||
| $19.87M | ||
| 28.39% | ||
| $22.37M | ||
| 31.95% | ||
| $20.20M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.17 | ||
| 8.42 | ||
| 8.42 | ||
| - | ||
| - | ||
| -0.24 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 5.65 | ||
| 1.75 | ||
| 1.09 | ||
| 0.63 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $112.21M | ||
| $128.65M | ||
| $143.01M | ||
| $132.44M | ||
| $30.80M | ||
| $15.73M | ||
| $18.78M | ||
| $3.71M | ||
| $579.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $47.63M | ||
| $49.81M | ||
| $325.00K | ||
| $0.00 | ||
| $325.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $29.61M | ||
| -$44.91M | ||
| -$146.00K | ||
| $0.00 | ||
| $29.61M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| Guggenheim | → | |
| Guggenheim | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Stifel | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with BDTX
FAQ
What is the ticker symbol for Black Diamond Therapeutics, Inc.?
The ticker symbol for Black Diamond Therapeutics, Inc. is NASDAQ:BDTX
Does Black Diamond Therapeutics, Inc. pay dividends?
No, Black Diamond Therapeutics, Inc. does not pay dividends
What sector is Black Diamond Therapeutics, Inc. in?
Black Diamond Therapeutics, Inc. is in the Healthcare sector
What industry is Black Diamond Therapeutics, Inc. in?
Black Diamond Therapeutics, Inc. is in the Biotechnology industry
What country is Black Diamond Therapeutics, Inc. based in?
Black Diamond Therapeutics, Inc. is headquartered in United States
When did Black Diamond Therapeutics, Inc. go public?
Black Diamond Therapeutics, Inc. initial public offering (IPO) was on January 31, 2020
Is Black Diamond Therapeutics, Inc. in the S&P 500?
No, Black Diamond Therapeutics, Inc. is not included in the S&P 500 index
Is Black Diamond Therapeutics, Inc. in the NASDAQ 100?
No, Black Diamond Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Black Diamond Therapeutics, Inc. in the Dow Jones?
No, Black Diamond Therapeutics, Inc. is not included in the Dow Jones index
When was Black Diamond Therapeutics, Inc. last earnings report?
Black Diamond Therapeutics, Inc.'s most recent earnings report was on November 6, 2025
When does Black Diamond Therapeutics, Inc. report earnings?
The next expected earnings date for Black Diamond Therapeutics, Inc. is May 11, 2026
Data Sources & References
- BDTX Official Website www.blackdiamondtherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1701541/000170154126000009/0001701541-26-000009-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1701541/000170154126000009/0001701541-26-000009-index.htm
- BDTX Profile on Yahoo Finance finance.yahoo.com/quote/BDTX
- BDTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bdtx